Molecular characterization of intrahepatic and extrahepatic hepatitis B virus (HBV) reservoirs in patients on suppressive antiviral therapy.
about
The hepatitis B virus ribonuclease H is sensitive to inhibitors of the human immunodeficiency virus ribonuclease H and integrase enzymesDetection of Hepatitis B Virus (HBV) Genomes and HBV Drug Resistant Variants by Deep Sequencing Analysis of HBV Genomes in Immune Cell Subsets of HBV Mono-Infected and/or Human Immunodeficiency Virus Type-1 (HIV-1) and HBV Co-Infected IndividualsNew insights into the evolutionary rate of hepatitis B virus at different biological scalesEfficacy and safety of tenofovir in a kidney transplant patient with chronic hepatitis B and nucleos(t)ide multidrug resistance: a case report.Hepatitis B virus quasispecies in hepatic and extrahepatic viral reservoirs in liver transplant recipients on prophylactic therapy.The hepatitis B virus ribonuclease H as a drug targetTGF-β suppression of HBV RNA through AID-dependent recruitment of an RNA exosome complex.How further suppression of virus replication could improve current HBV treatment.Clinical relevance of hepatitis B virus variantsRNA editing of hepatitis B virus transcripts by activation-induced cytidine deaminaseEvolving New Strategies for the Medical Management of Chronic Hepatitis B Virus Infection.New paradigms in hepatitis B management: only diamonds are forever.Therapeutic strategies for a functional cure of chronic hepatitis B virus infection.Clinical relevance of the study of hepatitis B virus covalently closed circular DNA.Requirement of CRTC1 coactivator for hepatitis B virus transcriptionEfficacy and safety of tenofovir disoproxil fumarate rescue therapy for chronic hepatitis B patients who failed other nucleos(t)ide analogs.Hepatitis B virus genetic diversity has minimal impact on sensitivity of the viral ribonuclease H to inhibitors.Purification and enzymatic characterization of the hepatitis B virus ribonuclease H, a new target for antiviral inhibitors.Efficacy of interferon for chronic hepatitis B in patients with nucleoside and nucleotide combination therapy failure.Compartmentalization of hepatitis B virus: Looking beyond the liverIntracellular levels of hepatitis B virus DNA and mutational patterns of the polymerase gene of hepatitis B virus in peripheral blood mononuclear cells of patients with lamivudine or telbivudine resistance.Hepatitis B virus (HBV) variants fluctuate in paired plasma and peripheral blood mononuclear cells among patient cohorts during different chronic hepatitis B (CHB) disease phases.High incidence of treatment-induced and vaccine-escape hepatitis B virus mutants among human immunodeficiency virus/hepatitis B-infected patients.Reactivation of hepatitis B after liver transplantation: Current knowledge, molecular mechanisms and implications in management.A novel stop codon mutation within the hepatitis B surface gene is detected in the liver but not in the peripheral blood mononuclear cells of HIV-infected individuals with occult HBV infection
P2860
Q28485228-75820965-5677-4A41-B40D-0540F07D51DEQ28548313-12226295-BB12-45E3-8EFE-A3E79470A54EQ28649472-36BB8DD4-B92B-4C2B-BB4C-22F2A46861D2Q34139592-814C4075-4299-4F5D-A944-1CE2DF41C7BFQ34175570-8B84978B-911E-4BF8-BAAF-25F94846A8AEQ35582561-2EE7A81B-4BE0-444E-B9C6-2BD8631F32CBQ35593692-48C4D22F-181C-4AEA-99B3-05CA0EC16597Q35622347-34FB2337-2F0E-41BB-B0FF-14310E0415DBQ35668730-E339086E-C1CA-41FB-9C5E-ABE9337AACD2Q36598091-73D513B6-30BB-4E24-950F-09D096F0E735Q37540212-0AA222D5-06CA-471B-B7FC-727CD97EAE09Q38588187-A94F3EEC-5E69-43BA-A5F7-39FB4E34CB1DQ38636988-116080E1-E7F8-438B-A824-7BFAA88C1EB4Q38685587-FACB25B0-11CA-42DC-8494-40D91318D31CQ38949360-7B666280-6C35-4183-9935-5CA79FA2C094Q39174722-602DA7BB-A35B-422F-9E3D-2B9472E4DFA6Q39332246-9C94988B-7D8F-422D-A794-79B0E96A18CCQ39671295-EC62C4C1-BC1B-491B-AF05-1EE160AC5134Q40957411-DE0A6283-1CCD-404E-97C6-292FFA9FC75AQ40994332-E44F2F2B-0FCE-4EA3-AEEC-2B2E7980F772Q41492511-C66CA779-2895-480B-9AB2-CE6459F094E7Q41746406-64AE6C2A-929C-4158-988A-E2B191547AF9Q43586321-4ED5BDE4-F0E6-4CDB-B1BC-2C061190049FQ52620441-B2B37D0D-E33F-4784-AA55-E1C801F2918CQ56979536-CF264E19-9271-4AF0-A29A-B085C1F59E94
P2860
Molecular characterization of intrahepatic and extrahepatic hepatitis B virus (HBV) reservoirs in patients on suppressive antiviral therapy.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Molecular characterization of ...... suppressive antiviral therapy.
@ast
Molecular characterization of ...... suppressive antiviral therapy.
@en
Molecular characterization of intrahepatic and extrahepatic hepatitis B virus
@nl
type
label
Molecular characterization of ...... suppressive antiviral therapy.
@ast
Molecular characterization of ...... suppressive antiviral therapy.
@en
Molecular characterization of intrahepatic and extrahepatic hepatitis B virus
@nl
prefLabel
Molecular characterization of ...... suppressive antiviral therapy.
@ast
Molecular characterization of ...... suppressive antiviral therapy.
@en
Molecular characterization of intrahepatic and extrahepatic hepatitis B virus
@nl
P2093
P2860
P1476
Molecular characterization of ...... suppressive antiviral therapy.
@en
P2093
C S Coffin
G van Marle
J P Roberts
M G Peters
N A Terrault
P M Mulrooney-Cousins
T I Michalak
P2860
P304
P356
10.1111/J.1365-2893.2010.01321.X
P577
2011-06-01T00:00:00Z